Desarrollo de la gestión del proceso general de la manipulación de los medicamentos peligrosos en las unidades de hospitalización a domicilio
- Maria A. Bernabeu Martinez 1
- Pedro García Salom 2
- Amparo Burgos San José 2
- Andrés Navarro Ruiz 3
- Javier Sanz Valero 1
- Carmina Wanden-Berghe 2
-
1
Universidad Miguel Hernández de Elche
info
-
2
Hospital General Universitario de Alicante
info
-
3
Hospital General Universitario de Elche
info
ISSN: 2530-5115
Year of publication: 2019
Volume: 3
Issue: 1
Pages: 9-23
Type: Article
More publications in: Hospital a Domicilio
Abstract
Objective: To identify associated hazards and to describe chemical risks arising from these in the process of handling of hazardous drugs (HD) in Home Hospitalization Units (HHU), as the initial phase of its risk assessment and which affect the security of healthcare professionals. Method: There was a consensus of experts (nominal group and documentary techniques) using a mixed method through two face-to-face rounds (meeting of participants and approval of proposals) and three masked rounds (review of the material on an individual basis). The analysis was applied to the field of home hospitalization and the stages of the process were designed using standardized graphical notation Business Process Modeling Notation. Results: It was obtained the specific flowchart for management and traceability of the HD, being characterized each of the phases of the general process, they were collected in a chart of stage management and operations of conservation, transportation and administration of HD in HHU, which served for the subsequent description of chemical hazards and exposure ways. Conclusions: The HD should be integrated in a standard management system in order to improve the safety of the patient and healthcare professionals, at the same time that the efficiency of resources are maximized and procedural incidents are minimized, ensuring the quality and the safety of the process of handling the HD on the HHU. It would be desirable, once the hazards have been identified, to carry out an assessment of the risks by following a systematic methodology and preventative approach that allows calibrating the probability of occurrence and severity of any adverse event.
Bibliographic References
- Jong T de, Pawlowska-Cyprysiak K, Hildt-Ciupińska K, Bos E, Nicolescu G, Trifu A, et al. Current and emerging occupational safety and health (OSH) issues in the healthcare sector, including home and community care: European Risk Observatory Report. Luxembourg: European Agency for Safety and Health at Work; 2015.
- Herrero Alonso JM, Gaspar Carreño M, Cercós Lleti AC. Medicamentos peligrosos: una carrera de fondo. Rev OFIL. 2018;28(1):9–10.
- Erce A, editor. Preventing occupational exposure to cytotoxic and other hazardous drugs: European Policy Recommendations. [monografía en Internet]. Brussels, Belgium: Rodhe Public Policy; 2016 [citada 5 nov 2018]. Disponible en: https://bit.ly/2qXKWHG
- American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm. 1990;47(5):1033–49. PMID: 2186621
- Burroughs GE, Connor TH, McDiarmid MA, Mead KR, Power LA, Reed LD. NIOSH Alert: preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Atlanta, USA: National Institute of Occupational Safety and Health (NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention; 2004. Report No.: 2004–165.
- Instituto Nacional de Seguridad e Higiene en el Trabajo (INSHT). Guía técnica para la evaluación y prevención de los riesgos relacionados con los agentes químicos presentes en los lugares de trabajo. Madrid, España: INSHT; 2013.
- Bernabeu Soria B, Mateo García M, Wanden-Berghe C, Cervera Peris M, Piñeiro Corrales G, Sanz-Valero J. Development of the management for parenteral nutrition traceability in a standard hospital. Farm Hosp. 2015;39(6):358–68. DOI: 10.7399/fh.2015.39.6.9689; PMID: 26618380
- Cervera Peris M, Alonso Roris VM, Santos Gago JM, Álvarez Sabucedo LM, Wanden-Berghe C, Sanz Valero J. Implantación de un sistema mSalud para la gestión y trazabilidad de la nutrición parenteral domiciliaria. Hosp Domic. 2017 Jul 28;1(3):129–39. DOI: 10.22585/hospdomic.v1i3.19
- Bernabeu-Martínez MA, Ramos Merino M, Santos Gago JM, Álvarez Sabucedo LM, Wanden-Berghe C, Sanz-Valero J. Guidelines for safe handling of hazardous drugs: A systematic review. PloS One. 2018;13(5):e0197172. DOI: 10.1371/journal.pone.0197172; PMID: 29750798
- Poveda JL, coordinador. Monografías de farmacia hospitalaria y atención primaria: Medicamentos peligrosos. Barcelona, España: Bayer Hispania SL; 2016.
- International Society of Oncology Pharmacy Practicioners Standards Committee. ISOPP Standards of Practice: Safe Handling of Cytotoxics. J Oncol Pharm Pract. 2007;13 Suppl:1–81. DOI: 10.1177/1078155207082350; PMID: 17933809
- The Hazardous Drug Consensus Group. Consensus Statement on the Handling of Hazardous Drugs: Per USP Chapter [monografía en Internet]. North Carolina, USA: Hazardous Drug Consensus Statement; 2017 [citada 5 nov 2018]. Disponible en: https://bit.ly/2qubr6V
- Poveda JL, Zamudio A, Cobos JL, Muedra M, Aparicio J, Barragán MB, et al. Documento de Consenso de Sociedades Científicas: Seguridad del paciente y del profesional sanitario en la preparación y administración de medicinas peligrosas. Madrid, España: Sociedades Científicas Españolas; 2015.
- Real Decreto 665/1997, de 12 de mayo, sobre la protección de los trabajadores contra los riesgos relacionados con la exposición a agentes cancerígenos durante el trabajo. Boletín Oficial del Estado, no 124, (24 de mayo de 1997).
- Real Decreto 374/2001, de 6 de abril, sobre la protección de la salud y seguridad de los trabajadores contra los riesgos relacionados con los agentes químicos durante el trabajo. Boletín Oficial del Estado, no 104, (1 de mayo de 2001).